United States - English - NLM (National Library of Medicine)

cardinal health, inc. - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox) - laxative for relief of occasional constipation - abdominal pain,nausea,or vomiting. - a sudden change in bowel habits lasting more than 2 weeks. - if you have already used a laxative for a week rectal bleeding or fails to have a bowel movement within one  hour of using this product. this may indicate a serious condition.

United States - English - NLM (National Library of Medicine)

c.b. fleet company, inc. - (in each tablespoon), docusate sodium 50 mg, stool softener - - for the prevention of dry, hard stools - for relief of occasional constipation - this product generally produces bowel movement in 12-72 hours

United States - English - NLM (National Library of Medicine)

c.b. fleet company, inc. - magnesium hydroxide (unii: nbz3qy004s) (magnesium cation - unii:t6v3lhy838, hydroxide ion - unii:9159uv381p) - saline laxative for relief of occasional constipation this product usually produces bowel movement in 1/2 to 6 hours

United States - English - NLM (National Library of Medicine)

lannett company, inc. - chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - purpose of chlorpheniramine maleate: antihistamine purpose of pseudoephedrine hydrochloride: nasal decongestant purpose of dextromethorphan hydrobromide: cough suppressant uses temporarily relieves common cold, hay fever or other upper respiratory allergy symptoms: - nasal congestion - runny nose - sneezing - cough

United States - English - NLM (National Library of Medicine)

c.b. fleet company, inc. - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox) - hyperosmotic laxative - for relief of occasional constipation - this product usually produces bowel movement ¼ to 1 hour

United States - English - NLM (National Library of Medicine)

c.b. fleet company, inc. - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox) - hyperosmotic laxative - for relief of occasional constipation - this product generally produces bowel movement in 1/4 to 1 hour

United States - English - NLM (National Library of Medicine)

vitality works, inc - aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), plantago major (unii: w2469wno6u) (plantago major - unii:w2469wno6u), matricaria recutita (unii: g0r4ubi2zz) (matricaria recutita - unii:g0r4ubi2zz), verbascum thapsus (unii: c9td27u172) (verbascum thapsus - unii:c9td27u172) -

United States - English - NLM (National Library of Medicine)

green choice for life pediatric - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - cough suppressant expectorant uses - temporarily relieves cough due to minor throat and bronchial irritation as may occur with the common cold and helps loosen phlegm (mucus) and thin bronchial sections to make coughs more productive. do not use - on child taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric, or emotional conditions, or parkinson’s disease), or for 2 weeks after stopping the maoi drug. if you do not know if your child's prescription drug contains an maoi, ask your doctor or pharmacist before taking this product. - if cough persists for more than one week, tends to recur, or is accompanied by fever, rash or persistent headache. a persisten coug may be a sign of a serious condition.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - clindamycin palmitate hydrochloride (unii: vn9a8jm7m7) (clindamycin - unii:3u02el437c) - clindamycin palmitate hydrochloride for oral solution, usp (pediatric) (clindamycin palmitate hcl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of colitis, as described in the boxed warning , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). anaerobes: serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis and postsurgical vaginal cuff infection. streptococci: serious respiratory tract infections; serious skin and soft tissue infections. staphylococci: serious respiratory tract infections; serious skin and soft tissue infections. pneumococci: serious respiratory tract infections. bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. to reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin palmitate hydrochloride for oral solution (pediatric) and other antibacterial drugs, clindamycin palmitate hydrochloride for oral solution (pediatric) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin.

United States - English - NLM (National Library of Medicine)

pharmacia & upjohn company llc - alprostadil (unii: f5td010360) (alprostadil - unii:f5td010360) - prostin vr pediatric sterile solution is indicated for palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival. such congenital heart defects include pulmonary atresia, pulmonary stenosis, tricuspid atresia, tetralogy of fallot, interruption of the aortic arch, coarctation of the aorta, or transposition of the great vessels with or without other defects. in infants with restricted pulmonary blood flow, the increase in blood oxygenation is inversely proportional to pretreatment po2 values; that is, patients with low po2 values respond best, and patients with po2 values of 40 torr or more usually have little response. prostin vr pediatric should be administered only by trained personnel in facilities that provide pediatric intensive care. none.